Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
Qui est le CEO de Sihuan Pharmaceutical Holdings Group Ltd ?
Dr. Weicheng Guo est le Executive Deputy Chairman of the Board de Sihuan Pharmaceutical Holdings Group Ltd, il a rejoint l'entreprise depuis 2006.
Quelle est la performance du prix de l'action SHPHY ?
Le prix actuel de SHPHY est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Sihuan Pharmaceutical Holdings Group Ltd ?
Sihuan Pharmaceutical Holdings Group Ltd appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quelle est la capitalisation boursière de Sihuan Pharmaceutical Holdings Group Ltd ?
La capitalisation boursière actuelle de Sihuan Pharmaceutical Holdings Group Ltd est de $0
Est-ce que Sihuan Pharmaceutical Holdings Group Ltd est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Sihuan Pharmaceutical Holdings Group Ltd, y compris 3 achat fort, 2 achat, 1 maintien, 0 vente et 3 vente forte
